BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23792171)

  • 21. Effects of fine particulate matter on the ocular surface: An in vitro and in vivo study.
    Yang Q; Li K; Li D; Zhang Y; Liu X; Wu K
    Biomed Pharmacother; 2019 Sep; 117():109177. PubMed ID: 31387168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A murine model of dry eye induced by topical administration of erlotinib eye drops.
    Yang QC; Bao J; Li C; Tan G; Wu AH; Ye L; Ye LH; Zhou Q; Shao Y
    Int J Mol Med; 2018 Mar; 41(3):1427-1436. PubMed ID: 29286080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye.
    Choi JH; Kim JH; Li Z; Oh HJ; Ahn KY; Yoon KC
    Korean J Ophthalmol; 2015 Apr; 29(2):131-7. PubMed ID: 25829831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astragalus Ⅳ ameliorates the dry eye injury in rabbit model via MUC1-ErbB1 pathway.
    Chu L; Ma S; Chen Z; Cao W
    Eur J Histochem; 2021 Apr; 65(2):. PubMed ID: 33792228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye.
    Kim YJ; Ryu JS; Park SY; Lee HJ; Ko JH; Kim MK; Wee WR; Oh JY
    Cornea; 2016 Apr; 35(4):536-42. PubMed ID: 26807900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effects of carbenoxolone, an 11β-HSD1 inhibitor, against chemical induced dry eye syndrome.
    Na YJ; Choi KJ; Park SB; Sung HR; Jung WH; Kim HY; Rhee SD; Kim KY
    Apoptosis; 2017 Nov; 22(11):1441-1453. PubMed ID: 28887719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring.
    Ferrari G; Bignami F; Giacomini C; Franchini S; Rama P
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1680-8. PubMed ID: 23404121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Topical Mucolytic Agents on the Tears and Ocular Surface: A Plausible Animal Model of Mucin-Deficient Dry Eye.
    Li X; Kang B; Woo IH; Eom Y; Lee HK; Kim HM; Song JS
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3104-3114. PubMed ID: 30025127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
    Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S
    Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tear production and ocular surface changes in experimental dry eye after elimination of desiccating stress.
    Yoon KC; Ahn KY; Choi W; Li Z; Choi JS; Lee SH; Park SH
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7267-73. PubMed ID: 21849424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomes Derived from Mouse Adipose-Derived Mesenchymal Stem Cells Alleviate Benzalkonium Chloride-Induced Mouse Dry Eye Model via Inhibiting NLRP3 Inflammasome.
    Wang G; Li H; Long H; Gong X; Hu S; Gong C
    Ophthalmic Res; 2022; 65(1):40-51. PubMed ID: 34530425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporine A eyedrops with self-nanoemulsifying drug delivery systems have improved physicochemical properties and efficacy against dry eye disease in a murine dry eye model.
    Bang SP; Yeon CY; Adhikari N; Neupane S; Kim H; Lee DC; Son MJ; Lee HG; Kim JY; Jun JH
    PLoS One; 2019; 14(11):e0224805. PubMed ID: 31738791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye.
    Li Z; Choi JH; Oh HJ; Park SH; Lee JB; Yoon KC
    Curr Eye Res; 2014 Sep; 39(9):871-8. PubMed ID: 24559509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Topical 5-Aminoimidazole-4-carboxamide-1-β-d-Ribofuranoside in a Mouse Model of Experimental Dry Eye.
    Sung MS; Li Z; Cui L; Choi JS; Choi W; Park MJ; Park SH; Yoon KC
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):3149-58. PubMed ID: 26024098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
    Hongyok T; Chae JJ; Shin YJ; Na D; Li L; Chuck RS
    Arch Ophthalmol; 2009 Apr; 127(4):525-32. PubMed ID: 19365035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic Effect of MK2 Inhibitor on Experimental Murine Dry Eye.
    Wu Y; Bu J; Yang Y; Lin X; Cai X; Huang C; Zheng X; Ouyang W; Li W; Zhang X; Liu Z
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4898-4907. PubMed ID: 28973340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of silk fibroin in murine dry eye.
    Kim CE; Lee JH; Yeon YK; Park CH; Yang J
    Sci Rep; 2017 Mar; 7():44364. PubMed ID: 28281688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Quercetin in a Mouse Model of Experimental Dry Eye.
    Oh HN; Kim CE; Lee JH; Yang JW
    Cornea; 2015 Sep; 34(9):1130-6. PubMed ID: 26203745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease.
    Ecoiffier T; El Annan J; Rashid S; Schaumberg D; Dana R
    Arch Ophthalmol; 2008 Dec; 126(12):1695-9. PubMed ID: 19064851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. α-Melanocyte-stimulating hormone ameliorates ocular surface dysfunctions and lesions in a scopolamine-induced dry eye model via PKA-CREB and MEK-Erk pathways.
    Ru Y; Huang Y; Liu H; Du J; Meng Z; Dou Z; Liu X; Wei RH; Zhang Y; Zhao S
    Sci Rep; 2015 Dec; 5():18619. PubMed ID: 26685899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.